News

Federal Advisory Panel Finds No Safety Signal With Vaccine


 

The National Vaccine Advisory Committee has endorsed a working group report concluding that no safety signals have been identified so far with the 2009 H1N1 influenza vaccine.

In a public teleconference, working group chair Dr. Marie McCormick said the group reviewed data for a total of 74 million doses of inactivated (injected) vaccine and 19 million doses of live attenuated (intranasal) H1N1 vaccine distributed as of around Christmastime.

They concluded that the data do not suggest a safety signal between the outcomes examined and the vaccine, defining “signal” as an outcome temporally occurring more than anticipated by chance alone.

No serious increases in adverse events have been observed to date in any of the pandemic H1N1 vaccine clinical trials, and a comparison of serious events reported to the Vaccine Adverse Events Reporting System have shown similar levels between the H1N1vaccine and the seasonal influenza vaccine, as well as other vaccines.

In addition, active surveillance systems that are using rapid-cycle analysis of prespecified outcomes have also been within expected values, said Dr. McCormick, the Sumner and Esther Feldberg professor of Maternal and Child Health at Harvard University, Boston.

However, she cautioned, the size of the population captured under active surveillance is still somewhat limited, and some of the prespecified event analyses have involved small numbers.

A new federal project called Post-Licensure Rapid Immunization Safety Monitoring (PRISM), designed to monitor H1N1 vaccine safety in real-time using data from large health plans covering approximately 10% of the U.S. population, was set to begin in the next few days.

“As more data are available through active surveillance, conclusions will be based on a larger accumulation of data. Larger samples may be needed to detect rare adverse events,” she said.

The NVAC members voted to endorse the report during the teleconference. It now goes to the U.S. assistant secretary for health, who will review and consider it for formal implementation.

Recommended Reading

Chikungunya Fever: Could an Outbreak Happen Here?
MDedge Pediatrics
Rotavirus Vaccine Cut Hospitalizations by 86%
MDedge Pediatrics
Addressing Parental Concerns About Vaccines
MDedge Pediatrics
Vaccine Combinations Appear Safe, Effective
MDedge Pediatrics
To Date, No Safety Signals of Concern With H1N1 Vaccine
MDedge Pediatrics
Deformational Plagiocephaly Not Tied to Frequent OM
MDedge Pediatrics
FDA Panel OKs Antibiotic For Pseudomonas in CF
MDedge Pediatrics
Study: One Dose of H1N1 Vaccine May Suffice
MDedge Pediatrics
CA-MRSA Found Less Often in Kids With Atopic Dermatitis
MDedge Pediatrics
Septic Trochanteric Bursitis in an Adolescent
MDedge Pediatrics